We evaluated the expression of several genes involved in tissue remodelling and bone development in patients with calcifi c tendinopathy of the rotator cuff. Biopsies from calcifi ed and non-calcifi ed areas were obtained from 10 patients (8 women and 2 men; average age: 55 years; range: 40-68) with calcifi c tendinopathy of the rotator cuff. To evaluate the expression of selected genes, RNA extraction, cDNA synthesis and quantitative polymerase chain reaction (PCR) were performed. A signifi cantly increased expression of tissue transglutaminase (tTG)2 and its substrate, osteopontin, was detected in the calcifi c areas compared to the levels observed in the normal tissue from the same subject with calcifi c tendinopathy, whereas a modest increase was observed for catepsin K. There was also a signifi cant decrease in mRNA expression of Bone Morphogenetic Protein (BMP)4 and BMP6 in the calcifi c area. BMP-2, collagen V and vascular endothelial growth factor (VEGF) did not show signifi cant differences. Collagen X and matrix metalloproteinase (MMP)-9 were not detectable. A variation in expression of these genes could be characteristic of this form tendinopathy, since an increased level of these genes has not been detected in other forms of tendon lesions.
Introduction
Calcifi c tendinopathy of the tendons of the rotator cuff is common in Caucasian populations, with a reported prevalence varying from 2.7 % to 22 %, mostly affecting women between 30 and 50 years (Bosworth, 1941; Lippmann, 1961; Welfling et al. 1965; Refior et al. 1987; Uthoff, 1997) . In 10 % of patients, the condition is bilateral and it usually involves the supraspinatus tendon (Bosworth, 1941; De Palma and Kruper, 1961; Ark et al., 1992) .
The pathogenesis of calcific tendinopathy is still debated, and two different theories have been developed: in the fi rst one, degeneration of tendon fi bres is regarded as the fi rst step, followed by the development of calcium deposits (Steinbrocker, 1972) . In the second one, Uhthoff and co-workers hypothesised that a favourable environment permits an active process of cell-mediated calcifi cation, usually followed by spontaneous phagocytic resorption (Uhthoff and Loehr, 1997) . However, the reason of the association of calcium deposition with the process of tendon degeneration is still unknown (Uhthoff and Loehr, 1997) .
Recently, Harvie et al. noted , in a retrospective cohort study of 102 consecutive patients with calcifi c tendinopathy, a signifi cantly higher prevalence of thyroid and oestrogen hormones metabolism alterations compared to a control population. When patients were classifi ed according to the presence or absence of endocrine disorders, no signifi cant differences between cohorts for mean pain scores, time off work, presence of bilateral calcifi c tendinopathy, or dominant arm involvement were observed (Harvie et al., 2007) . However, earlier onset of the symptoms, longer natural history and a higher proportion of patients undergoing surgery were evident in patients with associated endocrine disorders, suggesting a possible classifi cation of the disease in idiopathic and endocrine-related forms (Harvie et al., 2007) .
Achilles tendinopathy (Mokone et al., 2006) , rotator cuff tendinopathy (Gwilym et al., 2009 ) and tears of the quadriceps tendon (Longo et al., 2010) may have a genetic component. However, specifi c genes have not been associated with rotator cuff injuries yet (September et al., 2007) .
Attempts to reproduce the peculiar tendon environment of calcifi c tendinopathy have employed macrophages and synthetic apatite crystals and/or natural apatites (Cheung et al., 1981) . This approach might help to understand F Oliva et al. Calcifi c tendinopathy of the rotator cuff Table 1 . Primers employed for quantitative PCR using the Sybr Green technique.
how calcifi ed material can be reabsorbed, but it does not explain fully the pathological processes involved in the development of the lesion. Gene expression studies could provide some further insights in calcifi c tendinopathy, but few data are currently available on this disorder (Sweet and Green, 1981; Zaka et al. 2006 ). On the contrary, studies performed in overuse injuries of the supraspinatus tendon evidenced increased expression of cartilage-specifi c genes and down-regulation of tendon specifi c genes. These changes suggest that the phenotype of the supraspinatus tendon becomes more cartilage-like as a result of overuse (Archambault et al., 2007) . However, in a rat model, just 2 weeks of rest are often suffi cient to recover from the molecular and biochemical effects of 2 and 4 weeks of overuse (Jelinsky et al., 2008) .
Many proteins could be involved in calcifi cation or tendon rearrangement processes, playing different roles in the various phases of generation of calcifi cation and resorption. Among the possible candidates there are Bone Morphogenetic Proteins (BMPs) and transglutaminases (TGs). BMPs regulate calcifi cation processes in the bone (Rider and Mulloy, 2010) , but their role in tendon repair has not been completely clarifi ed yet. The major function of transglutaminases is the covalent crosslinking of one protein chain via a glutamine residue to a lysine residue of another protein chain in a reaction termed transamidation (Lorand and Graham 2003) . Transglutaminases are expressed in almost all mammalian tissues, and their importance has been highlighted in wound healing and tissue repair, bone development and apoptosis (Johnson et al., 2003; Nurminskaya et al. 2003; Iismaa et al., 2009) . Another possible player is osteopontin, a protein produced by osteoblasts that was shown to be involved in the anchoring of osteoclasts to the mineral of bone matrix (Reinholt et al., 1990) . Upregulation of osteopontin is associated with chondrocyte terminal differentiation (Franzen et al., 1989) , and a role of osteopontin in modulating crystal nucleation and growth in mineralizing tissues has been hypothesised. Osteopontin has been observed in cells surrounding tendon calcifi cations, although its role has not been further clarifi ed (Halverson, 2003) .
Different collagen types could also play a role in the generation of calcifi cation; type V collagen is a major component of the non-fi brous collagen of blood vessels, and increased amounts of type V collagen have been detected in association with the presence of many new blood vessels in the granulation tissue at 10 and 20 d during murine tendon healing. The authors also hypothesised that ectopic ossifi cation of murine healing tendons may be linked to reduced amounts of type V collagen (Brown et al., 1986) . On the other hand, type X collagen is a short chain collagen which has been associated with calcifi c cartilage and/or the expression of the hypertrophic chondrocyte phenotype (Stephens et al., 1992) .
Extracellular matrix can also be affected by the activity of metalloproteinases (MMPs), and signifi cant expression of the MMP9 has been detected during rotator cuff and Achilles tendon tears (Karousou et al., 2008; Lakemeier et al., 2011) . Moreover MMP-9 was the gelatinase required for the removal of denatured collagen fragments and mediated by the vascular invasion of hypertrophic cartilage callus in developing murine long bones (Colnot et al., 2003) .
VEGF has the potential to stimulate the expression of matrix metalloproteinases and inhibit the expression of tissue inhibitors of matrix metalloproteinases (TIMP) in various cell types (e.g., endothelial cells, fi broblasts, chondrocytes), and therefore this cytokine may play a signifi cant role in the pathogenetic processes of degenerative tendon disease (Pufe et al., 2005) .
We thus evaluated the expression of several genes involved in tissue remodelling and bone development in patients with calcific tendinopathy of the rotator cuff, comparing in particular the calcifi c area with the surrounding macroscopically normal tendon.
Materials and Methods

Patient selection
Ten patients (8 women and 2 men; average age: 55 years; range: 40-68), with symptomatic calcifi c tendinopathy for more than 6 months and who had failed conservative management which included oral non-opiate analgesics, non-steroidal anti-inflammatory drugs, and physical therapy, underwent routine arthroscopic removal of the calcifi ed deposits performed at our institution by the senior surgeons. Biopsies were also taken in all these patients from macroscopically healthy areas of the same tendons.
Patients included in this investigation showed at anterior-posterior, lateral and outlet plain radiographs evidence of calcifi c deposits in the subacromial space. Exclusion criteria were the presence of calcifi c deposits
Analysed Gene Forward Primer
Reverse Primer A n n e a l i n g temperature tTG2
AAGAGGAGCGGCAGGAGTAT which from the tendon extended into the insertion of the rotator cuff on the humeral head, and the detection at arthroscopy of other shoulder conditions. Moreover, patients with endocrinological or gynaecological diseases were excluded.
To obtain an external reference value for quantitative polymerase chain reaction (PCR) analysis, we used biopsies from intact supraspinatus tendons after arthroscopic stabilisation of shoulder instability from 10 different patients (5 women and 5 men; average age: 33; range 27-40). All patients gave written informed consent before enrolment in the study. All the procedures described in the present study received ethical approval from the Ethics Committee of the University of Rome.
Biopsy processing, RNA extraction and cDNA synthesis Biopsies were obtained during surgery both in control patients undergoing surgery for shoulder instability and in patients with calcifi c tendinopathy of the rotator cuff and in apparently healthy area, transferred to sterile microtubes, snap-frozen in liquid nitrogen, and preserved at -80 °C until processing.
RNA from normal tendons and calcifi c areas, as well as from controls, was extracted homogenising the biopsy in the presence of TRIzol (Invitrogen, Grand Island, NY, USA) using a micro manual homogeniser, and then continuing the procedure according to the manufacturer's protocol. RNA was quantified by spectrophotometry, and its integrity assessed by non-denaturing agarose gel. Two micrograms of total RNA were used as template for reverse transcription, performed using the High Capacity cDNA Archive kit which employs random primer hexamer (Applera, Foster City, CA, USA), according to manufacturer's protocol.
Real-time quantitative PCR mRNA levels of Bone Morphogenetic Proteins 2, 4 and 6 (BMP2, BMP4 and BMP6) were evaluated by real time PCR (qPCR) on an ABI 7900HT (Applera) using the Assays-on-Demand Gene Expression Products (Applera) according to the manufacturer's protocol.
Quantifi cation of tissue transglutaminase 2 (tTG2), collagen X, collagen V, VEGF, Matrix Metalloprotease 9 (MMP9), osteopontin, osteonectin, catepsin K was performed using the Sybr green method (Logan et al., 2009) . Primers were designed spanning an intron-exon junction, and their sequences are reported in Table 1. For each PCR reaction, 15 ng of cDNA were used as template. All analyses were carried out in triplicate. Results showing a discrepancy greater than 0.3 cycle between the samples were excluded.
Relative quantities present in each sample were assessed using the 2 -(ΔΔcT) method; the values obtained for each gene were normalised on a housekeeping gene (GAPDH) to correct for possible differences in the amount added to each PCR reaction. All normalised values were compared to an external control value obtained using cDNA obtained by retrotranscription of a pool of RNA obtained from the biopsies of the 10 patients undergoing Non-retrotranscribed RNAs were included in each amplifi cation plate, and the analysis regarded as valid if the fl uorescence intensity in the no-template control was zero.
Statistical analysis
Statistically significant differences between gene expression values detected in the calcifi c or non-calcifi c tissue were analysed by paired Student's t-test. Statistical analyses were performed using the SAS System Software (version 9.1) (SAS, Cary, NC, USA).
Results
To assess whether the presence of calcifi cation within the tendon could be associated with variation in the expression of genes associated with the ossifi cation processes, we firstly evaluated the expression of BMPs. We could not detect any difference in the level of expression of BMP2 in the calcifi c tissue as compared to the normal, i.e. non calcifi c tissue, obtained from the patients with calcifi c tendinopathy (Fig. 1) . On the other hand, the expression of BMP4 and BMP6 mRNA in the calcifi c area was signifi cantly decreased (p = 0.038 and p = 0.019, respectively).
We then analysed the expression of genes related to extracellular matrix, namely collagen V and X, catepsin K and tTG2. The mRNA levels of collagen V were similar in the normal and in the calcifi c tissue (Fig. 2) . Collagen X mRNA was not detectable, neither in the normal nor in the calcifi c tissue, as was MMP9 mRNA. On the other hand, there was an increased level of cathepsin K mRNA in the calcifi c tissue (p = 0.05). We also evaluated tTG2 mRNA level, detecting a signifi cant increase of its expression in the calcifi c areas (p = 0.031) (Fig. 2) .
Osteopontin and osteonectin can have a role in matrix remodelling, and we detected a signifi cant increase in osteopontin expression in biopsies of the calcifi c tissue (p = 0.038) (Figure 3) . On the contrary, no difference was observed in the expression of osteonectin mRNA. VEGF could affect matrix remodelling through its action on vascularisation, but its expression was not different between normal and calcifi c tissue (Fig. 3) . 
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Discussion
The aetiopathogenesis of calcifi c tendinopathy is still controversial, especially because it remains diffi cult to clarify the fi rst steps causing this condition and involved in the development of calcifi cations. These processes require several months, and biopsies of the pathologic cuff tendons are obtained only towards the end of the natural history of this disease, during the resorptive phase (Uhthoff, 1975) and when patients are symptomatic. Collagen disarray is the main extracellular matrix feature detected around the calcifi c deposits. This characteristic is similar to what observed in other tendinopathies (Garau et al. 2008; Longo et al., 2008; Sharma and Maffulli, 2008; Zafar et al., 2009) , which has prompted to hypothesise that a failed healing response may play a role in the development of calcific tendinopathy. However, why calcifi c deposits appear, which gene expression changes are associated to calcifi c tendinopathy, and which cells are involved in its development or resorption still remains to be determined.
Although various proteins could be involved in the different phases, available data have mainly been obtained on the expression of a few genes (Magra and Maffulli, 2007; Magra and Maffulli, 2008) . Takeuchi et al. detected osteopontin only in the cells adjacent to the calcifi ed area, identifying, morphologically, two distinct types of osteopontin positive cells, i.e. mononuclear fi broblastic cells and round-shaped mutinuclear cells, present in that area (Takeuchi et al., 2001) . The same group also reported the presence of multinucleated TRAP positive giant cells adjacent to the calcium deposits of the rotator cuff tendon, and Cathepsin K was immunolocalised in this type of cells (Nakase et al., 2000) .
Other genes, however, may play an important role in the various phases of calcifi c tendinopathy, including BMPs, collagens, VEGF, metalloproteases and transglutaminases, whose expression has never been tested in this type of tendon pathology. The possible involvement of these genes is also supported by evidence obtained in other tendon injuries: increased type II collagen expression has been detected in human rotator cuff tendinopathy (Maffulli et al., 2006; Sharma and Maffulli, 2005) , and we observed tTG2 and TG2 mRNAs down-regulation in all injured supraspinatus tendons (Oliva et al., 2009 ).
Here we report an expression analysis study on the expression of various genes usually involved in matrix rearrangement in the healthy or calcifi c tissue of patients with calcifi c tendinopathy. We observed an increased expression of Osteopontin, Cathepsin K and tTG2 mRNA in the calcifi c areas as compared to the level observed in the normal tissue derived from the same subject during surgery.
Osteopontin is a member of the SIBLING (Small Integrin-Binding Ligand N-linked Glycoprotein) family of proteins (Fisher and Fedarko, 2003) . SIBLING proteins are secreted matricellular proteins with RGD cell adhesion motif, proteins that also possess the ability to bind to the mineral phase of bones and teeth (Fisher and Fedarko, 2003) . Osteopontin is also a substrate for tTG2, since it presents two transglutaminase-reactive glutamines (Q34 and Q36), and treatment of osteopontin with TG2 produces high-molecular weight oligomers with increased collagenbinding capacity (Kaartinen et al., 1999; Higashikawa et al., 2007) In our series of patients with calcifi c tendinopathy of the rotator cuff, we detected an increased expression of both osteopontin and tTG2 transcripts in the calcifi ed areas, suggesting the presence of a possible common mechanism controlling both the transcription of the enzyme and its substrate. The increased production of both proteins could however be related to different processes according to the tissue in which it takes place. In bone, tTG2 is expressed by osteoblasts (Al-Jallad et al., 2006; Nurminskaya and Kaartinen, 2006) , and its crosslinking activity plays a role in the organisation of extracellular matrix. On the contrary, a combined increased expression of tTG2 and osteopontin has been detected in calcifi ed arteries of Gla-deficient mice, a model characterised by ectopic mineral deposition: this phenomenon has been interpreted as an inducible inhibitory mechanism of calcifi cation (Kaartinen et al., 2007) . In the same model, osteopontin was expressed close to macrophages, prompting the authors to suggest that osteopontin oligomers created by tTG2 may constitute a scaffold for macrophage adhesion and calcifi cation resorption (Kaartinen et al., 2007) . The effect of osteopontin on resorption is further supported by the observation that, in osteopontin KO mice, administration of recombinant osteopontin induced resorption of ectopic calcifi cations (Steitz et al., 2002) .
The increased expression of osteopontin and tTG2 could thus be compatible with their increased production in the calcifi c area, probably by osteoclast-like cells involved in the resorptive phase (Nakase et al., 2000) . A variation in expression of these genes could be, in theory, a fi nding characteristic of calcifi c tendinopathy, since an increased level of these genes has not been detected in other forms of tendon lesions (Maffulli et al., 2006; Archambault et al., 2007; Jelinsky et al., 2007) .
We also detected a down-regulation of BMP 4 and 6, a fi nding possibly related to the clinical stage at which our patients underwent surgery. BMPs can play an important role in cell proliferation and differentiation (Wu et al., 2007) , and the reduction in their mRNA levels in the calcifi c tissue could be associated with a reduced cellularity in this area, or may be one of its causes. Alternatively, the pattern of expression observed in these patients could be due to variations specifi c of the various phases of the disease, which take place at different time points. In fact, a recent investigation (Yee Lui et al., 2011) analysed the expression of BMPs in the ossifi ed failed tendon healing model of tendinopathy, showing an increased expression of BMP2 in the tendon matrix after 2 weeks, expression almost undetectable afterwards but in the chondroossifi cation sites. On the contrary, BMP4/7 had a bimodal expression, decreasing at 4 and 8 weeks.
Neovascularity has also been postulated as one of the mechanisms involved in the pathogenesis of calcifi c tendinopathy. However, when we analysed the mRNA levels of VEGF and Collagen V, they were similar in normal and calcifi c tissue. This fi nding, by itself, is not
Calcifi c tendinopathy of the rotator cuff suffi cient to reject this hypothesis, since neovascularisation could be present and play a role only in the fi rst phases of development of the lesion (Cook and Purdam, 2009 ).
In conclusion, we have identified several genes whose expression is increased in the frankly pathological areas of supraspinatus tendons of patients with calcifi c tendinopathy. Although our fi ndings paint only a partial picture of this process, they support some of the theories about the pathogenesis of this condition. The role of BMPs in the production of calcifi c tendinopathy lesions still remains to be elucidated, given their physiological expression in these lesions, although it cannot be excluded that they exerted an initial action, and, once the process initiated, their expression returned to normal. Further investigation, involving also protein studies, will be necessary to further characterise this process, and identify possible future therapeutic targets.
Discussion with Reviewers
Reviewer I: I would expect agarose gel electrophoresis data for visual demonstration of the data. Authors: We now provide the PCR performed on the samples obtained from two of the ten patients evaluated, for whom we still had enough RNA to perform the analysis. Since end-point PCR is not able to provide a precise quantification, especially if a plateau is reached, we performed experiments at 25, 30, 35 cycles to detect possible differences. A description of the methodology, including the primers used, follows below. RNA and retrotranscription was performed as described for quantitative PCR. Qualitative PCR was performed using 30 ng of cDNA as template, in a fi nal volume of 25 μL, in buffer containing 1.5 mM MgCl 2 and 150 nM of forward and reverse primers. For tTG2, Osteopontin, F Oliva et al. Calcifi c tendinopathy of the rotator cuff and Cathepsin K the primers employed were the same as shown in Preliminary experiments conducted at various cycles allowed us to identify a range in which we were able to observe differences among the samples before a plateau was reached. For this reason, amplifi cations were performed for 35 cycles except for GAPDH, in which 30 cycles were used (Fig. 4 ).
Reviewer I: Why did you not select TGFβ-1,2,3 that are usually involved in osteogenesis? Authors: We agree that TGFβ is usually involved in osteogenesis, a process markedly different from the production of calcifications observed in calcific tendinopathy (see below). Although we agree that it may be useful to perform an analysis of the expression of these genes, the scarcity of the material obtained obliged us to select those that were assessed. The collection of further selected samples will be necessary to evaluate other possible genes involved in the pathogenesis.
Reviewer I:
What is the role of infl ammation in calcifi c tendinitis and how does that correlate with their fi ndings? Authors: Infl ammatory cells and vessels are notably absent during the formative phase. Also, in the resting phase, fi brocollagenous tissue borders the foci of calcifi cation without evidence of infl ammation, thereby indicating termination of deposition (Archer et al., 1993) . Typical cells of inflammation have been detected during the resorptive phase. Specifi cally, Nakase et al. clarifi ed the nature of the multinucleated cells located near the calcium deposits. These were positive for cathepsin K protein and mRNA, and had a typical osteoclast phenotype. The same research group later detected osteopontin only in the cells adjacent to the calcifi ed area, identifying, morphologically, two distinct types of osteopontin positive cells, i.e., mononuclear fi broblastic cells and round-shaped multinuclear cells (Nakase et al., 2000; Takeuchi et al., 2001 , text references). Other proteins or cells typical of the infl ammation cascade still remain to be investigated in the process of calcifi c tendinopathy.
Reviewer I: Is calcifi c tendinitis similar to heterotopic ossifi cation? Authors: Heterotopic ossifi cation is a common phenomenon after spinal cord injury, head injury, neurological disorders, burns and other trauma, and joint arthroplasty. Periarticular ossifi cations after shoulder surgery have been known to occur since the 19th century, at an incidence of up to 27 %. After arthroscopic and minimally invasive shoulder surgical procedures were introduced and came into broad use, reports about heterotopic ossifi cation became rare (Kircher et al., 2007) . Heterotopic ossifi cation is, by defi nition, the formation of bone within soft tissue. It is generally assumed that primitive mesenchymal cells stimulated by, for example, surgical trauma differentiate into osteoblastic cells, and produce osteoid that is fi nally mineralised and transformed into bone tissue. (Chalmers et al., 1975) . The main feature of the calcifi c tendinopathy is the calcium deposits inside the rotator cuff tendon and not in the periarticular soft tissue such as capsule, muscles and ligaments, with no apparent concomitant cause.
Reviewer I: Can the authors speculate the potential role of primary myoblasts in calcifi c tendinitis? It is known that they play an important role in bone regeneration and fracture healing! Authors: To our knowledge, primary myoblasts have not been detected around the calcium deposits in calcifi c tendinopathy. In the literature, several cells have been found in the various stage of the condition. The precalcifi c stage is characterised by metaplasia of the tendinous tissue into fibrocartilage. Separated by chondrocytes and fi brocartilaginous tissue septae, calcium crystals are deposited primarily in matrix vesicles that coalesce to form large foci of calcifi cation (Uhthoff and Loehr, 1997, text reference).
The formative phase is characterised by multifocal calcifi c deposits, separated by fi brocollagenous tissue or fi brocartilage. The latter consists of easily distinguishable chondrocyte-like cells, within a matrix showing various degrees of metachromasia. (Archer et al., 1993) . Young mesenchymal cells, epithelioid cells, leukocytes, lymphocytes, macrophages, and multinucleated giant cells then surround the deposits in an attempt to phagocytise them during the resorptive phase. The last phase is the post-calcifi c stage. Granulation tissue with young fi broblast and newly formed capillaries can be found around the calcifi cation, in contrast with well-formed scars with vascular channels and maturing fi broblast following the long axis of the tendon fi bres (Uhthoff and Loehr, 1997, text reference).
Reviewer II: What was the power of the statistical comparisons? I would expect that there is signifi cant variation between samples, and n = 10 may be insuffi cient to pick up differences. Authors: We agree that the number of patients is limited, but it is very diffi cult to fi nd a large number of patients with similar clinical features in a limited period of time. Given the small number of samples, the power of the statistical comparisons was below 0.800 (0.680 for BMP4, 0.753 for BMP6, but lower for collagen V, about 0.430). With 10 patients, this study has a power of 0.80 (at least) of demonstrating a 0.3 difference at a two-sided 0.05 signifi cance level.
